Institute of Cell Biology (Cancer Research), Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
Int J Cancer. 2014 Feb 15;134(4):832-43. doi: 10.1002/ijc.28422. Epub 2013 Aug 29.
Composite lymphomas (CL) represent the occurrence of two distinct lymphomas in the same patient. Often, CL share a common cellular origin, thus representing a unique model to investigate the multistep genetic path leading to lymphomagenesis in general and to the specific development of each distinct lymphoma component in particular. Here, we present the molecular analysis of a case consisting of an unusual Hodgkin lymphoma (HL) and a mantle cell lymphoma (MCL), intimately admixed within one another in lymph nodes and bone marrow yet phenotypically distinct, in a patient who first presented with splenic/leukemic MCL two years earlier. MCL and Hodgkin and Reed/Sternberg (HRS) cells harbored identical immunoglobulin (Ig) VH gene rearrangements with shared somatic mutations, proving their common clonal origin from a (post-)germinal center (GC) B cell. This also demonstrates the (post-)GC origin of MCL with mutated IgV genes. Both lymphomas carried the same CCND1/IGH translocation and, unexpectedly for HL, expressed cyclin D1 and OCT2. Thus, HRS cells are able to preserve IGH locus activity (otherwise usually silenced in HL) to promote expression of an oncogene translocated into this locus. Both lymphoma populations further showed an identical TP53 function-impairing mutation, and later acquired a TP53 heterozygous deletion independently from one another (convergent evolution). The surprisingly close genetic relationship of the lymphomas, together with their histological intermingling and the clinical history of the patient, suggests subclonal evolution of HL from MCL as a plausible pathway in alternative to that so far described in CL, i.e. separate development from a common precursor.
复合淋巴瘤(CL)是指同一患者同时发生两种不同的淋巴瘤。通常,CL 具有共同的细胞起源,因此代表了一个独特的模型,可以研究导致淋巴瘤发生的多步遗传途径,以及特别是每种独特淋巴瘤成分的特定发展。在这里,我们介绍了一例由霍奇金淋巴瘤(HL)和套细胞淋巴瘤(MCL)组成的病例的分子分析,在同一个患者的淋巴结和骨髓中,这些淋巴瘤紧密混合在一起,但表型上却截然不同,该患者两年前首次表现为脾/白血病 MCL。MCL 和霍奇金氏细胞和里德/斯特恩伯格氏细胞(HRS)细胞具有相同的免疫球蛋白(Ig)VH 基因重排,具有共享的体细胞突变,证明它们具有共同的克隆起源,来自(生发中心后)B 细胞。这也证明了 MCL 具有突变的 IgV 基因的(生发中心后)起源。两种淋巴瘤均携带相同的 CCND1/IGH 易位,并且出乎意料的是,HL 还表达了 cyclin D1 和 OCT2。因此,HRS 细胞能够保留 IGH 基因座的活性(否则通常在 HL 中沉默),以促进易位到该基因座的致癌基因的表达。两种淋巴瘤群体进一步显示出相同的 TP53 功能丧失突变,并且后来各自独立地获得了 TP53 杂合性缺失(趋同进化)。淋巴瘤之间惊人的密切遗传关系,加上它们的组织学混合以及患者的临床病史,表明 HL 从 MCL 亚克隆进化是一种替代目前在 CL 中描述的途径,即从共同前体独立发展。